The Blood and Marrow Transplant Program (BMT) at University of Minnesota Masonic Children's Hospital is among the best in the world. We were the first institution to successfully complete a bone marrow transplant– back in 1968. And since then, we have continued to lead the world in providing excellent, compassionate BMT care to children and adolescents.
University of Minnesota Health’s renowned BMT Program brings together the most respected research and clinical leaders in blood and marrow transplantation. We’re the site of innovative treatments, research studies and clinical trials with our trailblazing researchers investigating new frontiers in stem cell therapy and immunotherapy.
We combine world-leading BMT physicians with specialists from across many related disciplines to bring the experience and expertise of a whole team to your child’s bedside. From diagnosis, through treatment, and on into long-term survivorship–we’re right here with you.
What We DoAt University of Minnesota Masonic Children's Hospital, we perform the two main types of stem cell transplant:
- Autologous transplant – uses the body’s own stem cells and typically only used for patients with solid organ cancers
- Allogeneic transplant – uses well-matched stem cells from another person. As above, allogeneic stem cell transplant can be completed with stem cells from one of many sources: bone marrow, peripheral blood or umbilical cord blood. An ideal match may be found by testing close relatives of the patient (related donor) or from a volunteer unrelated to the patient (unrelated donor).
We care for patients with blood cancers, including leukemia and lymphoma, as well as solid organ cancers. We specialize in caring for patients with rare, devastating diseases like epidermolysis bullosa, Hurler syndrome, adrenoleukodystrophy, and Fanconi anemia. We provide transplant to patients with immune deficiencies and red blood cell disorders, like sickle cell disease and thalassemia. We are also one of the world’s largest umbilical cord blood transplant centers. In addition to stem cell transplant, we provide cutting edge gene therapy trials for several of these disorders as well. Learn more about the conditions we treat.
We also offer an extensive, long-term follow-up program for survivors of childhood cancers. We provide risk-based evaluation, monitoring and care in the years following transplant with your child’s unique needs in mind.Learn more about our Childhood Cancer Survivor Program.